patentprosecution
Getting the Most from Medical-Use Claims in Australia
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims drafted as "method of medical treatment" or "Swiss-form" claims.
Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics Inc. and other companies [2021] EWCA Civ 1279 What are the
Patent Examination Practice for Novelty in the Field of Life Sciences in China
When evaluating the novelty of claims in life sciences and pharmaceutical, compared with EPO, the examination practice in China is more stringent when determining whether
Notes to Patent Drafters: Common Issues with Broad Specifications in Canada
The Canadian Patent Act imposes an unyielding relationship between the requirement for a written description of the invention and claims for which patent protection is sought. A
Prosecution Pathway for Pharma & Bio Patents in India
Prosecution pathway for pharma & bio patents in india – part 1 The Indian pharmaceutical industry, often referred to as "the pharmacy of the world"
How to Focus on Small Molecules in Written Description and Enablement
Korean practice is quite strict, with respect to requirements for claiming small molecules, which are usually prepared by organic synthesis. The basic rules are (i)
Get our insights delivered from us to your inbox.